Evidence map›Paper›PMID 39658575›Full record

ArticleNature communications2024

Automated discovery of experimental designs in super-resolution microscopy with XLuminA.

Carla Rodríguez, Sören Arlt, Leonhard Möckl, Mario Krenn

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Chromatix: a differentiable, GPU-accelerated wave-optics library.bioRxiv : the preprint server for biology · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Carla RodríguezMax Planck Institute for the Science of Light, Erlangen, Germany. carla.rodriguez@mpl.mpg.de.ORCID http://orcid.org/0000-0001-9045-9306
Sören ArltMax Planck Institute for the Science of Light, Erlangen, Germany.
Leonhard MöcklMax Planck Institute for the Science of Light, Erlangen, Germany. leonhard.moeckl@mpl.mpg.de.ORCID http://orcid.org/0000-0003-1387-886X
Mario KrennMax Planck Institute for the Science of Light, Erlangen, Germany. mario.krenn@mpl.mpg.de.ORCID http://orcid.org/0000-0003-1620-9207

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Driven by human ingenuity and creativity, the discovery of super-resolution techniques, which circumvent the classical diffraction limit of light, represent a leap in optical microscopy. However, the vast space encompassing all possible experimental configurations suggests that some powerful concepts and techniques might have not been discovered yet, and might never be with a human-driven direct design approach. Thus, AI-based exploration techniques could provide enormous benefit, by exploring this space in a fast, unbiased way. We introduce XLuminA, an open-source computational framework developed using JAX, a high-performance computing library in Python. XLuminA offers enhanced computational speed enabled by JAX's accelerated linear algebra compiler (XLA), just-in-time compilation, and its seamlessly integrated automatic vectorization, automatic differentiation capabilities and GPU compatibility. XLuminA demonstrates a speed-up of 4 orders of magnitude compared to well-established numerical optimization methods. We showcase XLuminA's potential by re-discovering three foundational experiments in advanced microscopy, and identifying an unseen experimental blueprint featuring sub-diffraction imaging capabilities. This work constitutes an important step in AI-driven scientific discovery of new concepts in optics and advanced microscopy.

Identifiers

PMID39658575
PMCPMC11632100

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.